Ligand Pharmaceuticals LGND Return on invested capital

Return on invested capital at other companies

Royalty PharmaRPRX

8.7%-2.7pp

Roivant SciencesROIV

-25.6%—

Relay Therapeutics, Inc.RLAY

-44.8%-8.3pp

Ionis PharmaceuticalsIONS

-80.3%+2,757pp

Innoviva, Inc.INVA

15.7%—

Opko HealthOPK

-3.7%-1.6pp

FAQ

What is Ligand Pharmaceuticals's return on invested capital?

Ligand Pharmaceuticals (LGND) reported return on invested capital of 8.5% in Q2 2026.

How has Ligand Pharmaceuticals's return on invested capital changed year-over-year?

Ligand Pharmaceuticals's return on invested capital increased by 288.7% year-over-year, from -4.5% to 8.5%.

What is the long-term trend for Ligand Pharmaceuticals's return on invested capital?

Over 5 years (2020 to 2025), Ligand Pharmaceuticals's return on invested capital has grown at a -5.9% compound annual growth rate (CAGR), from 5.4% to 4%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.